Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Our pricing system is unavailable. You are viewing list price.
Please call 1-800-766-7000 to place your order or try our site again later.

VEGFD Mouse anti-Human, Clone: OTI1C7, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA526886

Catalog No. PIMA526886



Description

Description

Several forms of VEGF have been identified, including VEGF, VEGF-B, VEGF-C and VEGF-D (also designated FIGF). Characteristic of VEGF proteins, the central region of VEGF-D contains eight cysteine residues. These residues are essential for homodimerization. VEGFD may play a role in tumor progression, as it is induced by c-Fos, which is required for conversion of early stage tumors to maligt tumors. It has been observed that overexpression of VEGF-D induces morphological changes in fibroblasts.
Specifications

Specifications

VEGFD
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3
O43915
Vascular endothelial growth factor D [Precursor]; VEGF-D; c-fos-induced growth factor; FIGF; FIGF; VEGFD;
Mouse
IgG2a
100 μL
-20° C, Avoid Freeze/Thaw Cycles
Primary
2277
Immunohistochemistry (Paraffin), Western Blot
OTI1C7
Unconjugated
VEGFD
Liquid
VEGFD
Human recombit protein fragment corresponding to amino acids 89-205 of FIGF produced in E.coli
Affinity Chromatography
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit